Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | February 16, 2024 05:31pm

Gainers

  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 13.3% to $0.37 during Friday's after-market session. The market value of their outstanding shares is at $4.3 million.
  • Dyadic International (NASDAQ:DYAI) stock moved upwards by 12.12% to $1.48. The company's market cap stands at $42.6 million.
  • Annovis Bio (NYSE:ANVS) shares increased by 8.33% to $11.3. The market value of their outstanding shares is at $119.5 million.
  • Sagimet Biosciences (NASDAQ:SGMT) shares increased by 7.71% to $8.12. The market value of their outstanding shares is at $259.0 million.
  • Motus GI Hldgs (NASDAQ:MOTS) shares rose 7.04% to $0.68. The company's market cap stands at $1.0 million.
  • ProKidney (NASDAQ:PROK) stock rose 6.99% to $1.68. The company's market cap stands at $114.0 million.

Losers

  • Universe Pharmaceuticals (NASDAQ:UPC) stock decreased by 21.6% to $1.93 during Friday's after-market session. The market value of their outstanding shares is at $7.0 million.
  • Equillium (NASDAQ:EQ) stock declined by 12.62% to $2.41. The market value of their outstanding shares is at $84.7 million.
  • Kazia Therapeutics (NASDAQ:KZIA) stock decreased by 9.34% to $0.32. The company's market cap stands at $8.4 million.
  • Bright Green (NASDAQ:BGXX) stock decreased by 7.95% to $0.21. The market value of their outstanding shares is at $37.9 million.
  • Lucy Scientific Discovery (NASDAQ:LSDI) stock decreased by 7.02% to $0.2. The company's market cap stands at $3.5 million. As per the news, the Q2 earnings report came out 2 days ago.
  • NextCure (NASDAQ:NXTC) shares decreased by 6.85% to $1.36. The market value of their outstanding shares is at $37.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ANVS BGXX DYAI EQ KZIA LSDI MOTS NXTC PROK SGMT UPC VRPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist